AHSG and fatty liver disease: Increased in patients with NAFLD, levels reduced after improvement of the disease.Fetuin-A is involved in steatosis of the liver and metabolic syndrome, not the underlying inflammatory process.Fetuin-A plays a role in the progression of nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH), indicating the association between Fetuin-A and steatosis.